BASILEA Logo (USPTO, 27.12.2007)
USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke BASILEA wurde als Wort-Bildmarke am 27.12.2007 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 29.09.2009 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "IR CANCELLED; US REGISTRATION CANCELLED".
| Markenform | Wort-Bildmarke |
| Aktenzeichen | 79050107 |
| Registernummer | 3689485 |
| Anmeldedatum | 27. Dezember 2007 |
| Veröffentlichungsdatum | 14. Juli 2009 |
| Eintragungsdatum | 29. September 2009 |
Markeninhaber
CH-4005 Basel
Markenvertreter
Waren und Dienstleistungen
1
chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
5
Pharmaceutical preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical preparations, namely, for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anestesiology; Pharmaceutical preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only
42
research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1379050107